News | February 09, 2010

FDA Radiation Reduction Program Targets CT, Nuclear Medicine, Fluoroscopy

February 9, 2010 - The U.S. Food and Drug Administration says it is starting a program designed to reduce unnecessary medical radiation exposure that will focus on three types of imaging procedures: computed tomography (CT), nuclear medicine and fluoroscopy. The FDA considers those procedures the greatest contributors to total U.S. radiation exposure and use much higher radiation doses than other radiographic procedures, such as standard X-rays, dental X-rays and mammography.

FDA’s Center for Devices and Radiological Health (CDRH) radiation safety programs involve enforcement of mandatory requirements in addition to partnerships and voluntary programs that promote the safe use of radiation-emitting products.
The goal of the programs is to ensure that the public and professionals are informed of the risks posed by different types of radiation emissions and radiation-emitting products and ensure patients receive the appropriate radiation dose using the appropriate, medically necessary imaging exam at the appropriate time.

The programs are designed to promote radiation safety, so that:

- Manufacturers design products that are safe;
- Users are aware of how to appropriately use radiation-emitting electronic products, and are able to understand radiation safety and protection principles;
- Patients and consumers are aware of basic radiation risk and protection concepts and protected from hazardous or unnecessary radiation emissions; and
- Regulators are able to collect and disseminate appropriate information and take action on this information when necessary.

For more information: http://www.fda.gov/Radiation-EmittingProducts/RadiationSafety/default.htm

Related Content

Study Demonstrates First Human Application of Novel PET Tracer for Prostate Cancer

Transaxial 11Csarcosine hybrid PET/CT showed a (triangulated) adenocarcinoma in the transition zone of the anterior right prostate gland on PET (A), CT (B), and a separately obtained T2?weighted MR sequence (C) with resulting PET/MRI registration (D). Image courtesy of M. Piert et al., University of Michigan, Ann Arbor, Mich.

News | Radiopharmaceuticals and Tracers | August 16, 2017
In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the...
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | Computed Tomography (CT) | August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
The American Lung Association created LUNG FORCE, a national movement to defeat lung cancer
News | Lung Cancer | August 02, 2017
To raise public awareness of lung cancer—the leading cancer killer of men and women—the American Lung Association's...
GE’s DoseWatch is a digital informatics solution that automatically collects, monitors and reports on radiation dose indices for diagnostic imaging exams
News | Radiation Dose Management | July 31, 2017
GE Healthcare announced that it has licensed computed tomography (CT) organ dosimetry technology developed at Duke...
Contrast Media from Bayer, trends in contrast media and developments in contrast media
Feature | Contrast Media | July 28, 2017 | By Dave Fornell
Here are several updates in medical imaging ...
New York Hospital Finds Significant Cost Savings With Toshiba’s Aquilion One CT
News | Computed Tomography (CT) | July 25, 2017
In five years, Kaleida Health’s Stroke Care Center (SCC) at the Gates Vascular Institute in Buffalo, N.Y., has realized...
Samsung Introduces FDA-Cleared BodyTom Elite CT Scanner
Technology | Computed Tomography (CT) | July 24, 2017
Samsung announced U.S. Food and Drug Administration (FDA) approval of the BodyTom Elite, an upgraded version of its...
X-ray performed on a GE Optima 646 DR system. The FDA has updated its radiology reporting forms on its website.
News | Business | July 24, 2017
July 24, 2017 — The U.S.
Overlay Init